JNJ : Analysis & Opinions

  • Showing 101-190 of 190 items
  • <<
  • 1
  • 2
  1. Slow And Steady ETFs Outperforming

    January 3, 2012
    Low volatility ETFs lead the way in 2011.
  2. 2011's Biggest Mergers and Acquisitions

    December 30, 2011
    M&A activity rebounded in a big way in 2011. Here's a look back at the biggest mergers and acquisitions during the year. ...
  3. 2011 - Another Sick Year For Larger Med-Tech

    December 29, 2011
    Larger healthcare companies are still getting sickly returns in the market.
  4. Stryker Falling Back To Earth

    December 16, 2011
    Stryker Corp's stock offers the potential for above-average shareholder returns with modest downside risk.
  5. Uncertainty Still Means Discount For WellPoint

    November 30, 2011
    Uncertainty still means discount for WellPoint.
  6. Solid Dividend-Paying Companies

    November 25, 2011
    If you are looking to add dividends to your portfolio, don't miss these stocks.
  7. Canadians, Look Before You Leap South

    November 22, 2011
    Before painting their portfolios red, white, and blue, Canadian income investors need to understand the drawbacks of playing ...
  8. Is Third Time The Charm For Gilead?

    November 22, 2011
    Gilead is going all in on Hep C, as it acquires Pharmasset in a massive deal.
  9. Covidien Delivers Once Again

    November 21, 2011
    Covidien is overlooked and undervalued.
  10. If CareFusion Can Execute, This Is A Major Bargain

    November 9, 2011
    CareFusion has to make some improvements, but it could really reward investors.
  11. Dendreon's Chinese Water Torture

    November 3, 2011
    Dendreon's Provenge continues to shape up as a major disappointment.
  12. Zimmer Looking To Escape Its Value Trap

    October 31, 2011
    Zimmer continues to trade at a very reasonable forward P/E.
  13. Big Dividends, Small Risk

    October 31, 2011
    Businesses that payout nice dividends can offer reasonable substitutes for some investors.
  14. Abbott Labs Joins The Separation Movement

    October 24, 2011
    Abbott is joining the separation movement that is sweeping across corporate America. The company plans to break into a medical ...
  15. Stryker Scraping By

    October 24, 2011
    Stryker's growth is modest, but the stock potential is surprising.
  16. High Yielding Equities

    October 21, 2011
    Despite the market volatility, there are still some stocks and ETFs that pay above-average dividend yields.
  17. Protect On The Downside With J&J

    October 21, 2011
    J&J trades at a reasonable forward P/E and offers investors downside protection.
  18. Is Jabil Quietly Loading Both Barrels?

    September 30, 2011
    Jabil's revenue is holding up better than its customers.
  19. Berkshire Buys Shares And Controversy

    September 29, 2011
    Berkshire announced its intention to buy back shares, but what does that mean for investors?
  20. Attractive Dividend Stocks To Watch

    September 27, 2011
    Dividend yields, despite how insignificant they may seem, are a major component of equity returns as times goes on
  21. Big Yields In A Low-Rate Environment

    September 12, 2011
    Over a period of years, it's likely that carefully chosen dividend-paying stocks will provide a higher return than Treasuries ...
  22. Medtronic's Healthy Growth Outlook

    August 29, 2011
    Medtronic's stock deserves a close look.
  23. Bonds That Look Better Than Treasuries

    August 14, 2011
    Instability in the political and economic spheres has meant a shift from Treasuries to corporate bonds in recent weeks, writes ...
  24. What Do AA+ And AAA Credit Ratings Mean?

    August 10, 2011
    Whether you held a AAA or AA+ rating, the difference didn't seem to matter to Mr. Market on Monday.
  25. BD Healthy, But No Great Bargain

    August 9, 2011
    BD is not the cheapest health care name, but it comes with a lot of quality.
  26. The Perpetual Boston Scientific Turnaround Story

    August 4, 2011
    Another quarter brings another hope for better days at BSX.
  27. Covidien's Image Starting To Change

    August 3, 2011
    Find out why Covidien is much better than many investors assume.
  28. Better Budgets, Better Times For Robots

    July 12, 2011
    With healthier budgets at hospitals, robots are looking better and better.
  29. Immucor Passes Its Last Test

    July 5, 2011
    Immucor gets a fair price for its shareholders.
  30. Pleasure And Pain For Pfizer

    June 27, 2011
    Pfizer sees a new pain pill make it to market and another sent back to the drawing board.
  31. 10 Drug Stocks for Safety and Yields

    June 26, 2011
    Big pharma is an attractive destination for traders and investors looking for safety, yields, and solid value in the current ...
  32. Dow 30 Stocks With Good Dividends

    June 21, 2011
    For all of you dividend fiends out there, we combed through the Dow 30 to find some of the best yielding stocks...
  33. Johnson & Johnson Surrenders In Stents

    June 17, 2011
    JNJ makes a tough and surprising, but ultimately wise, decision.
  34. Should Investors Worry If Gen-Probe Doesn't Sell Out?

    June 10, 2011
    Not selling may be the best move Gen-Probe can make for its shareholders.
  35. Conglomerates With A Dividend Angle

    June 6, 2011
    Well-run conglomerates can be great additions to income-oriented portfolios.
  36. Medtronic Still Muddling Through

    May 27, 2011
    Medtronic is going nowhere fast, but the quality hasn't left.
  37. Obagi's Pitfalls Provide Investment Opportunity

    May 24, 2011
    Obagi's stock dropped 24% after announcing a 13-cent loss in its first quarter. Find out why this presents an opportunity ...
  38. Mergers In Orthopedics Could Heat Up Stocks

    May 18, 2011
    Major med-tech players have picked up where they left off before the recession and credit crisis.
  39. 4 Stocks Hitting Highs During The Pullback

    May 6, 2011
    Four stocks that are holding up well during a short-term market pullback.
  40. Despite The Noise, Abbott Still A Value

    April 25, 2011
    Abbott has made some curious moves of late, but the value is still there.
  41. J&J Beats Analyst Expections, But Not Its Rivals

    April 25, 2011
    Tangible signs of sustained sales growth and consistent profit expansion are still absent at J&J.
  42. 6 Overbought Stocks To Watch

    April 25, 2011
    Let's take a look at a few stocks that have recently entered overbought territory because these could be candidates for a ...
  43. DexCom Shows Diabetes Still A Growth Industry

    March 9, 2011
    DexCom shows that, although times are tough, people will still adopt better technology.
  44. Multiple Value Creation Opportunities For Stryker

    February 2, 2011
    Stryker could end up being acquired by a larger rival, but company growth trends remain appealingly robust in their own right. ...
  45. Risk With Little Reward At Johnson & Johnson

    January 27, 2011
    A number of Johnson & Johnson rivals trade at equally appealing valuations and have their acts together in terms of product ...
  46. Unilever: U.K.'s Go-To Company

    January 27, 2011
    Looking ahead, Unilever is in an excellent position to deliver solid growth, cash flow and return on invested capital over ...
  47. Consolidation In The Orthopedic Market?

    January 20, 2011
    Consolidation in the orthopedic market has been fueling market rumors.
  48. A Look At The Drug Makers Of 2010

    December 30, 2010
    Drug makers faced an uphill fight in 2010 and next year is looking to be just as tough.
  49. Big Dividends In Large Caps

    December 17, 2010
    These five stocks pay good dividends and can help balance an otherwise unstable portfolio.
  50. Emulate Buffett For Fun And Profit - Mostly Profit

    December 14, 2010
    We take a peek at some of Berkshire Hathaway's top holdings to see what Warren Buffett sees.
  51. Expected Increase In Research And Development

    November 8, 2010
    Research & Development (R&D) is the key to success in the pharmaceutical industry, but just how much of an impact ...
  52. 5 Stocks That Are Haunting Investors

    October 27, 2010
    These stocks have given quite a scare to their investors, but the true horror lies in whether they can recover or not.
  53. Johnson And Johnson Resilient Despite Recalls

    October 22, 2010
    Despite a bad quarter for Johnson and Johnson, the actual results show the competitive advantages of this company.
  54. BIG Dividends, BIG Returns

    October 22, 2010
    High dividend paying stocks are present in many industries. But do you know how to analyze a balance sheet to ensure that ...
  55. Invest In The Lip Balm Portfolio

    October 5, 2010
    Themed portfolios can often exceed established ones in performance - and the lip balm portfolio is just one example.
  56. The Average Lifespan Of S&P 500 Companies

    August 25, 2010
    The longevity of S&P companies will affect how you invest in them.
  57. Boost Your Dividends With These Large Caps

    August 20, 2010
    These stocks will inject higher dividends into your portfolio.
  58. Johnson & Johnson Needs A Catalyst

    July 22, 2010
    It's difficult to find a catalyst for growth to return to more historical levels at Johnson & Johnson.
  59. Stocks To Guard Your Portfolio

    July 1, 2010
    Finding the right stock to reduce volatility is not as exciting, but it is essential to building a lasting portfolio and ...
  60. Pharmaceuticals With Big Returns

    June 22, 2010
    These intriguing Pharmaceuticals currently have big returns.
  61. Pepsi's Repurchase And Dividend Increase Is Bad For Shareholders

    March 17, 2010
    Find out why there are far bettter moves for management to make, and how Pepsi's latest announcement is bad for its shareholders. ...
  62. Serious Dividend Yields For The Opportunistic Investor

    March 11, 2010
    Boring or not, dividends are valuable, especially when they are part a great business that has strong future earnings potential. ...
  63. Value-able Investing Lessons From Yacktman Funds

    March 10, 2010
    Yacktman's investing techniques can help individual investors outperform the market over the long haul.
  64. Asset OutFlows: A Contrarian Buy Signal

    March 2, 2010
    Money is fleeing the stock market once again. History says the time to buy is now.
  65. J&J: The Most Recession-Resistant Stock In The World?

    January 27, 2010
    This consumer products giant continues to demonstrate why it's top of its class.
  66. Procter Hardly A Gamble

    January 25, 2010
    Basic necessities are a safe play no matter what the economic state.
  67. 5 Reasons Gold Is The Next Bubble To Burst

    January 22, 2010
    What goes up must come down.
  68. Dividend Yields You Won't Believe

    January 18, 2010
    When they can be obtained as part of an effort to buy quality companies on the cheap, dividends can create enormous value ...
  69. The Best Capital Allocator In Consumer Goods

    January 15, 2010
    These six stocks were chosen as favorites in the consumer goods field for 2010. Do they live up to the hype?
  70. Why Today's Market Dictates Pessimism

    November 18, 2009
    Investing as if the markets can only go up is a recipe for disaster, while embracing pessimism will keep you in the game. ...
  71. McDonald's: Investors (And Employees) Are Lovin' It

    October 28, 2009
    McDonald's has one of the best 401(k) plans around. It's no wonder this stock is soaring.
  72. Funds With Low Fees And Commissions

    September 3, 2009
    Fees lead to diminishing returns, so it's best to invest in funds with little or no fees.
  73. No More Tears For Johnson & Johnson

    May 21, 2009
    While it looks like Johnson & Johnson may have a slower year in 2009, investors would be doing themselves a favour by ...
  74. Convertible Securities In Today's Market

    April 30, 2009
    John Calamos, the father of convertible investing, moderated a panel on convertible bonds at the Milken Global Conference ...
  75. Avoid Unions At All Costs

    April 24, 2009
    Misinformation thrown about in the auto bailout is a clear sign for investors to avoid companies with significantly unionized ...
  76. Baxter A Healthy Healthcare Holding

    April 22, 2009
    Baxter's recent results demonstrate why it continues as a leader in its industry and should be considered a core healthcare ...
  77. Investing In State Farm's Starting Five

    February 23, 2009
    Creativity is the key to developing investment ideas.
  78. No More Tears For Johnson & Johnson

    January 23, 2009
    Its wide range of products and international exposure give this stock a positive long-term outlook.
  79. Making Your Investments Pay: Equity Income ETFs

    December 4, 2008
    The flight to extreme quality has reduced treasury yields to non-inflation beating instruments. Income ETFs are now ripe ...
  80. A Matrixx For Killing The Common Cold

    November 3, 2008
    Matrixx Initiatives works to build a name for itself in the competitive over-the-counter cold medicine market.
  81. Aging Population Feeds Global Healthcare Demand

    October 30, 2008
    Investing in foreign-based healthcare providers is as important as investing in healthcare providers with a global reach. ...
  82. Is Stock Market Capitulation Over?

    October 15, 2008
    We examine the present market for clues to where and when we'll see a bottom.
  83. Back To The Basics: Safety And Diversification

    September 19, 2008
    With investors freaking out, it is time to examine a small portfolio of stocks to gain diversification and safety.
  84. CVS Posts Record Profits

    May 5, 2008
    Despite the slowing U.S economy, CVS is still going strong.
  85. Five Dividend Darlings For Your Portfolio

    April 24, 2008
    Does your portfolio lack a solid dividend yield? Here are five dividend-paying stocks to snap up while their yields are high. ...
  86. Johnson & Johnson Blows Away Q1 (JNJ)

    April 20, 2007
    J&J beat its Q1 consensus number with ease, so where is the stock is headed from here?
  87. P/E Ratios Still Matter

    February 1, 2007
    High P/E stocks are almost always more glamorous than their low P/E counterparts, but are they more profitable?
  88. Bristol-Myers Hurt By Plavix, Saved By Demographics (BMY)

    November 16, 2006
    Despite BMY's recent struggles with its Plavix sales, favorable demographics make the stock a good investment to consider. ...
  89. Boston Scientific Shaken, But Not Stirred (BSX)

    November 8, 2006
    Boston Scientific looks poised for higher per share valuations in the future.
  90. Weakness At Target A Reason For Concern (TGT)

    July 18, 2006
    With an economic slowdown in the mix, Target may feel the pinch more than investors expect.
  91. Pfizer, Pass the Rolaids

    June 12, 2006
    $15 billion for its consumer products unit won’t cure Pfizer’s ailing stock.
  • Showing 101-190 of 190 items
  • <<
  • 1
  • 2
Trading Center